Tag: Biocept Inc (NASDAQ: BIOC)


Biocept Inc (Nasdaq: BIOC) to Work together with Quest Diagnostics to Deliver Progressive NGS-Based Liquid Biopsy Testing for Patients with Lung Cancer

Biocept Inc (NASDAQ: BIOC) today proclaimed a partnership with Quest Diagnostics Inc (NYSE: DGX) to provide research laboratory analysis facilities to Quest patients for its Target Selectorâ„¢ NGS-based liquid biopsy directed lung cancer section. Quest Diagnostics is the foremost supplier of investigative info facilities, counting in advanced diagnostics. The Biocept […]